Echinocandins in Ocular Therapeutics

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Ocular Pharmacology and Therapeutics

• Publication date

  2017-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/jop.2016.0186PMID 28437176
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Voriconazole

  2019cited by this paper
• Subconjunctival Injection of Fluconazole in the Treatment of Fungal Alternaria Keratitis

  2016cited by this paper
• β-glucan: Crucial component of the fungal cell wall and elusive MAMP in plants.

  2016cited by this paper
• Fusarium: Molecular Diversity and Intrinsic Drug Resistance

  2016cited by this paper
• Cladosporium keratitis – a case report and literature review

  2015cited by this paper
• Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients

  2015cited by this paper
• Topical 5% Natamycin With Oral Ketoconazole in Filamentous Fungal Keratitis: A Randomized Controlled Trial

  2015cited by this paper
• Topical 5% Natamycin With Oral Ketoconazole in Filamentous Fungal Keratitis: A Randomized Controlled Trial.

  2015cited by this paper
• Natamycin in the treatment of fungal keratitis: a systematic review and Meta-analysis.

  2015cited by this paper
• Wickerhamomyces anomalus fungal keratitis responds to topical treatment with antifungal micafungin.

  2015cited by this paper
• Clinical utility of caspofungin eye drops in fungal keratitis.

  2014cited by this paper
• Epidemiology of Echinocandin Resistance in Candida

  2014cited by this paper
• Fungal keratitis caused by Beauveria bassiana: drug and temperature sensitivity profiles: a case report

  2014cited by this paper
• Discovery and development of first in class antifungal caspofungin (CANCIDAS®)--a case study.

  2014cited by this paper
• Intrastromal voriconazole for deep recalcitrant fungal keratitis: a case series

  2014cited by this paper
• Toxicity and Pharmacokinetics of Intrastromal Injection of Amphotericin B in a Rabbit Model

  2014cited by this paper
• Estimated Burden of Keratitis — United States, 2010

  2014cited by this paper
• Aspergillus Tubingenesis Endophthalmitis after Cataract Surgery with Implantation of Preloaded Intraocular Lens

  2014cited by this paper
• Pharmacokinetics and Safety of Intravitreal Caspofungin

  2014cited by this paper
• Photochemical toxicity of drugs intended for ocular use

  2014cited by this paper
• Intraocular Penetration of Intravenous Micafungin in Inflamed Human Eyes

  2013cited by this paper
• Antifungals In Eye Infections: Drugs And Routes Of Administration

  2013cited by this paper
• Candida Infections, Causes, Targets, and Resistance Mechanisms: Traditional and Alternative Antifungal Agents

  2013cited by this paper
• In Vitro Susceptibility of Candida Species to Four Antifungal Agents Assessed by the Reference Broth Microdilution Method

  2013cited by this paper
• Antifúngicos em infecções oculares: drogas e vias de administração

  2013cited by this paper
• First case of fungal keratitis caused by Pestalotiopsis clavispora

  2013cited by this paper
• Mycotic keratitis: epidemiology, diagnosis and management.

  2013cited by this paper
• Are Echinocandins Better Than Azoles for Invasive Candidiasis?

  2013cited by this paper
• Pharmacokinetics and Pharmacodynamics of Anidulafungin for Experimental Candida Endophthalmitis: Insights into the Utility of Echinocandins for Treatment of a Potentially Sight-Threatening Infection

  2012cited by this paper
• Notes from the field: Multistate outbreak of postprocedural fungal endophthalmitis associated with a single compounding pharmacy - United States, March-April 2012.

  2012cited by this paper
• Total synthesis and structure–activity relationships of caspofungin-like macrocyclic antifungal lipopeptides

  2012cited by this paper
• Discrepancy of in-vitro data and clinical efficacy of micafungin against Candida tropicalis endophthalmitis

  2012cited by this paper
• Echinocandin Antifungal Drugs in Fungal Infections

  2012cited by this paper
• Combination of Intracameral and Intrastromal Voriconazole in the Treatment of Recalcitrant Acremonium Fungal Keratitis

  2012cited by this paper
• Medical interventions for fungal keratitis.

  2012cited by this paper
• Reply to swine flu and hemophagocytic syndrome

  2012cited by this paper
• Resistant Fusarium Keratitis Progressing to Endophthalmitis

  2012cited by this paper
• Amphotericin primarily kills yeast by simply binding ergosterol

  2012cited by this paper
• Clinical and microbiological characteristics of fungal keratitis in the United States, 2001-2007: a multicenter study.

  2011cited by this paper
• Treatment of Severe Fungal Keratitis With Subconjunctival Amphotericin B

  2011cited by this paper
• Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania donovani

  2011cited by this paper
• Epidemiology and antifungal resistance in invasive aspergillosis according to primary disease - review of the literature

  2011cited by this paper
• Antifungal Resistance and New Strategies to Control Fungal Infections

  2011cited by this paper
• Intraocular caspofungin: in vitro safety profile for human ocular cells

  2011cited by this paper
• Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin and its impact on use and costs - review of the literature

  2011cited by this paper
• Penetration of Topically Administered 0.5-Percent Caspofungin Eye Drops into Human Aqueous Humor

  2011cited by this paper
• Intraocular Penetration of Micafungin in Patient with Candida albicans Endophthalmitis

  2011cited by this paper
• Treatment of Alternaria Keratitis with Intrastromal and Topical Caspofungin in Combination with Intrastromal, Topical, and Oral Voriconazole

  2011cited by this paper
• Intravitreal voriconazole for the treatment of Aspergillus chorioretinitis

  2011cited by this paper
• Evaluation of intrastromal voriconazole injection in recalcitrant deep fungal keratitis: case series

  2011cited by this paper
• Therapeutic efficacy of intracameral amphotericin B injection for 60 patients with keratomycosis.

  2010cited by this paper
• Epidemiology of ulcerative keratitis in Northern California.

  2010cited by this paper
• Evaluating retinal toxicity of intravitreal caspofungin in the mouse eye.

  2010cited by this paper
• Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis

  2010cited by this paper
• Recurrent fungal keratitis following penetrating keratoplasty: an unusual source of infection.

  2010cited by this paper
• Ocular Drug Delivery

  2010cited by this paper
• The comparison of solitary topical micafungin or fluconazole application in the treatment of Candida fungal keratitis

  2010cited by this paper
• Successful topical application of caspofungin in the treatment of fungal keratitis refractory to voriconazole.

  2010cited by this paper
• Topical Amphotericin B and Subconjunctival Injection of Fluconazole (Combination Therapy) Versus Topical Amphotericin B (Monotherapy) in Treatment of Keratomycosis

  2010cited by this paper
• Topical and Oral Voriconazole in the Treatment of Fungal Keratitis

  2009cited by this paper
• Alternaria Keratitis: Clinical Presentation and Resolution With Topical Fluconazole or Intrastromal Voriconazole and Topical Caspofungin

  2009cited by this paper
• A Case of Endogenous Trichosporon Endophthalmitis Treated with Micafungin and Voriconazole

  2009influential reference
• Intraocular penetration of voriconazole and caspofungin in a patient with fungal endophthalmitis.

  2009cited by this paper
• Toxicities and pharmacokinetics of subconjunctival injection of liposomal amphotericin B

  2009cited by this paper
• In Vitro Susceptibility of Clinical Isolates of Aspergillus spp. to Anidulafungin, Caspofungin, and Micafungin: a Head-to-Head Comparison Using the CLSI M38-A2 Broth Microdilution Method

  2009cited by this paper
• Aqueous Humor Concentrations of Topically Administered Caspofungin in Rabbits

  2008cited by this paper
• Ocular distribution of intravenously administered micafungin in rabbits

  2008cited by this paper
• Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints

  2008cited by this paper
• Medical management approach to infectious keratitis

  2008cited by this paper
• Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods.

  2008cited by this paper
• Natamycin Blocks Fungal Growth by Binding Specifically to Ergosterol without Permeabilizing the Membrane*

  2008cited by this paper
• A case of endogenous Candida albicans endophthalmitis resolving with itraconazole treatment without recourse to vitrectomy

  2007cited by this paper
• Treatment of two postoperative endophthalmitis cases due to Aspergillus flavus and Scopulariopsis spp. with local and systemic antifungal therapy

  2007cited by this paper
• Therapeutic Effect of Intracameral Amphotericin B Injection in the Treatment of Fungal Keratitis

  2007cited by this paper
• Efficacy of Topical Caspofungin in Experimental Fusarium Keratitis

  2007cited by this paper
• The Effects of Caspofungin and Voriconazole in Experimental Candida Endophthalmitis

  2007cited by this paper
• Paradoxical Effect of Echinocandins across Candida Species In Vitro: Evidence for Echinocandin-Specific and Candida Species-Related Differences

  2007cited by this paper
• Micafungin: a new echinocandin.

  2006cited by this paper
• Intravitreal voriconazole for the treatment of endogenous Aspergillus endophthalmitis.

  2006cited by this paper
• Candida albicans endophthalmitis after extracorporeal shock wave lithotripsy in a patient with liver cirrhosis.

  2006cited by this paper
• In Vitro Susceptibilities of Candida spp. to Caspofungin: Four Years of Global Surveillance

  2006cited by this paper
• Voriconazole Concentration in Human Aqueous Humor and Plasma during Topical or Combined Topical and Systemic Administration for Fungal Keratitis

  2006cited by this paper
• Amphotericin B is still the drug of choice for invasive aspergillosis.

  2006cited by this paper
• Fungal endophthalmitis caused by Aspergillus ustus in a patient following cataract surgery.

  2006cited by this paper
• New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage.

  2006cited by this paper
• Use of voriconazole in candida retinitis

  2005cited by this paper
• Efficacy of Caspofungin against Aspergillus terreus

  2005cited by this paper
• Treatment of Candida infections with amphotericin B lipid complex.

  2005cited by this paper
• Intracorneal injection of amphothericin B for recurrent fungal keratitis and endophthalmitis.

  2005cited by this paper
• Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole.

  2005cited by this paper
• Retinal Function Assessed by ERG Before and After Induction of Ocular Aspergillosis and Treatment by the Anti-fungal, Micafungin, in Rabbits

  2005influential reference
• Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin.

  2005cited by this paper
• Topical Caspofungin for Treatment of Keratitis Caused by Candida albicans in a Rabbit Model

  2005cited by this paper
• Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis.

  2005cited by this paper
• Toxicological Evaluation of Micafungin Ophthalmic Solution in Rabbit Eyes

  2005cited by this paper
• Severe fungal keratitis treated with subconjunctival fluconazole.

  2005cited by this paper
• In Vitro Activity of Anidulafungin against Selected Clinically Important Mold Isolates

  2004cited by this paper
• Micafungin Enhances Neutrophil Fungicidal Functions against Candida Pseudohyphae

  2004cited by this paper
• Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans.

  2004cited by this paper
• Ocular toxicity of experimental intravitreal itraconazole

  2004cited by this paper

• 8-Hydroxyquinoline derivative as a promising antifungal agent to combat ocular fungal infections.

  2025cites this paper
• Comprehensive insights into the role of nanocarriers in advancing azole-based ocular therapeutics

  2025cites this paper
• First Isolation of a Multi-azole-Resistant Aspergillus fumigatus cyp51A TR46/Y46F/F70L Mutant in a Patient with Fungal Keratitis

  2025cites this paper
• Ultrastructural and Immunohistochemical Study of Double and Combined Intravitreal Administration of Antifungal Agents in the Retina of New Zealand Albino Rabbits: An Experimental Protocol

  2025cites this paper
• Nanoformulations of Antifungal Agents for the Management of Ocular Fungal Infections

  2025cites this paper
• Clinical Insights: Antimicrobial Therapy for Infectious Uveitis

  2024cites this paper
• Efficacity of anidulafungin in the treatment of Candida endophthalmitis.

  2024cites this paper
• Review of Nanoformulations for Treating Ocular Fungal Infections

  2024cites this paper
• Advances in the Pharmacological Treatment of Fungal Corneal Ulcers

  2024cites this paper
• Fungal Keratitis: Diagnosis, Management, and Recent Advances

  2024cites this paper
• Intestinal bacteria—a powerful weapon for fungal infections treatment

  2023cites this paper
• Network pharmacology, molecular docking-driven, Qbd-Engineered antifungal in-situ gel loaded with voriconazole nanostructured lipid carriers

  2023cites this paper
• Eye fungal infections: a mini review

  2023influential citation
• Thermosensitive Tri-Block Polymer Nanoparticle-Hydrogel Composites as Payloads of Natamycin for Antifungal Therapy Against Fusarium Solani

  2022cites this paper
• Conventional Antifungals for Invasive Infections Delivered by Unconventional Methods; Aerosols, Irrigants, Directed Injections and Impregnated Cement

  2022cites this paper
• Disseminated Aspergillus lentulus infection in a heart transplant recipient: a case report.

  2022cites this paper
• In vitro antifungal susceptibility of Fusarium species and Aspergillus fumigatus cultured from eleven horses with fungal keratitis.

  2022cites this paper
• A recent update on therapeutic potential of vesicular system against fungal keratitis

  2022cites this paper
• Effect of Sub-Conjunctival, Topical and Systemic Fluconazole On Refractory Fungal Keratitis

  2022cites this paper
• Management of Filamentous Fungal Keratitis: A Pragmatic Approach

  2022cites this paper
• Successful management of recalcitrant fungal keratitis with topical caspofungin

  2022cites this paper
• Effectiveness of Voriconazole in Treating Fungal Keratitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2022cites this paper
• Fungal keratitis: A review of clinical presentations, treatment strategies and outcomes.

  2021cites this paper
• Recent Perspectives in the Management of Fungal Keratitis

  2021cites this paper
• Ηistological Effects of Intravitreal Injection of Voriconazole and Micafungin: A Review

  2021influential citation
• Histological Effects of Intravitreal Injection of Antifungal Agents in New Zealand White Rabbits: An Electron Microscopic and Immunohistochemical Study

  2020influential citation
• Diseases of the eye

  2020cites this paper
• Carboxyvinyl Polymer and Guar-Borate Gelling System Containing Natamycin Loaded PEGylated Nanolipid Carriers Exhibit Improved Ocular Pharmacokinetic Parameters

  2020influential citation
• The role of fungi in fungal keratitis.

  2020cites this paper
• OCULAR DELIVERY OF NATAMYCIN SOLID LIPID NANOPARTICLE LOADED MUCOADHESIVE GEL: FORMULATION, CHARACTERIZATION AND IN VIVO STUDY

  2020cites this paper
• Pharmacologic therapy of mycotic keratitis.

  2019cites this paper
• Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery.

  2019cites this paper
• Updates in Ocular Antifungal Pharmacotherapy: Formulation and Clinical Perspectives

  2019cites this paper
• Evolving nanotechnological trends in the management of mycotic keratitis

  2019cites this paper
• Challenges in the Polyene- and Azole-Based Pharmacotherapy of Ocular Fungal Infections

  2019cites this paper
• Recent advances in topical nano drug-delivery systems for the anterior ocular segment.

  2018cites this paper
• Formulation Development, Optimization, and In Vitro-In Vivo Characterization of Natamycin-Loaded PEGylated Nano-Lipid Carriers for Ocular Applications.

  2018cites this paper
• Current perspectives on natamycin in ocular fungal infections

  2017cites this paper
• A novel, tomographic imaging probe for rapid diagnosis of fungal keratitis

  2017cites this paper
• Echinocandins in antifungal pharmacotherapy

  2017cites this paper